SBIR-STTR Award

Microfluidic CD Biochips for Enzyme-Linked Immunosorbent Assays
Award last edited on: 5/10/2023

Sponsored Program
STTR
Awarding Agency
NSF
Total Award Amount
$630,305
Award Phase
2
Solicitation Topic Code
BT
Principal Investigator
I-Ching Tang

Company Information

Bioprocessing Innovative Company

4734 Bridle Path Court
Dublin, OH 43017
   (614) 761-1552
   bictang@sbcglobal.net
   N/A

Research Institution

Ohio State University

Phase I

Contract Number: 0419585
Start Date: 7/1/2004    Completed: 6/30/2005
Phase I year
2004
Phase I Amount
$100,000
This Small Business Technology Transfer Research (STTR) Phase I project proposes to develop a novel microchip based enzyme-linked immunosorbent assay on compact disk (CD-ELISA) for rapid detection of biological molecules. The commercial application of this project will be for detection of food-borne pathogens and toxins. The proposed system is expected to have the advantages of low cost, simple operation, parallel detection, fast response, and ease of automation

Phase II

Contract Number: 0548716
Start Date: 12/15/2006    Completed: 11/30/2009
Phase II year
2007
(last award dollars: 2008)
Phase II Amount
$530,305

The Small Business Technology Transfer (STTR) Phase II project will develop a low-cost and mass-producible lab-on-a-chip platform for molecular and biological analyses. The platform is a microfluidic CD for Enzyme-Linked Immunosorbent Assays (ELISA) that reduces cost, accelerates results, and improves reliability of analyses for food borne contaminants, cancer diagnoses and environmental contamination.The CD-ELISA technology platform merges two scientific areas - polymer microfabrication and biotechnology - and can substantially reduce manufacturing costs, improve device performance, and enable the production of low-cost and high-efficiency devices. Moreover, as such a device would be more affordable it will enable point-of-use results for a broader spectrum of molecular and biological testing.